Smith-Magenis Sendrom’lu Bir Olgu

Yıl 2018, Cilt: 7 Sayı: 2, 63 - 65, 01.10.2018

Zeynep Esener İbrahim Tekedereli

Öz

Smith-Magenis senromu SMS fasiyal dismorfizm, gelişim basamaklarında gecikme, bilişsel gerilik, karakteristik davranış paterni ve uyku bozuklukları ile karakterize genetik bir hastalıktır. Bu olgu sunumunda fasiyal dismorfizm, gelişimsel gecikme ve bilişsel gerilik nedeni ile SMS tanısı alan bir olgu sunulmuştur.

Anahtar Kelimeler

Smith-Magenis sendromu, 17p11.2 delesyon sendromu, RAI1

A Case of Smith-Magenis Syndrome

Öz

Smith-Magenis syndrome is a genetic disorder characterized by facial dysmorphism, developmental delay, cognitive retardation, characteristic behavior pattern and sleep disturbance. In this study we report a Smith Magenis Syndrome patient with facial dysmorphism, developmental delay and cognitive retardation.

Anahtar Kelimeler

Smith-Magenis syndrome, 17p11.2 deletion syndrome, RAI1

Kaynakça

• Potocki L, Shaw CJ, Stankiewicz P, et al. Variability in clinical phenotype despite common chromosomal deletion in Smith- Magenis syndrome [del(17)(p11.2p11.2)]. Genet Med 2003; 5(6): 430-4.
• Edelman EA, Girirajan S, Finucane B, et al. Gender, genotype, and phenotype differences in Smith-Magenis syndrome: a meta-analysis of 105 cases. Clin Genet 2007; 71(6): 540-50.
• Vilboux T, Ciccone C, Blancato JK, et al. Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith- Magenis syndrome without the 17p11.2 deletion. PLoS One 2011; 6(8): e22861.
• Greenberg F, Guzzetta V, Montes de Oca-Luna R, et al. Molecular analysis of the Smith- Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2). Am J Hum Genet 1991; 49(6): 1207-18.
• Williams SR, Zies D, Mullegama SV, et al. Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity. Am J Hum Genet 2012; 90(6): 941-9.
• Laje G, Bernert R, Morse R, et al. Pharmacological treatment of disruptive behavior in Smith-Magenis syndrome. Am J Med Genet C Semin Med Genet 2010; 154C(4): 463-8.
• De Leersnyder H, De Blois MC, Claustrat B, et al. Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr 2001; 139(1): 111-6.
• De Leersnyder H, Bresson JL, de Blois MC, et al. "Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome." J Med Genet 2003; 40(1): 74-8.
• Zori RT, Lupski JR, Heju Z, et al. Clinical, cytogenetic, and molecular evidence for an infant with Smith-Magenis syndrome born from a mother having a mosaic 17p11.2p12 deletion. Am J Med Genet 1993; 47(4): 504-11.